What is known about CBD’s benefits in cancer treatment?
CBD (cannabidiol), a promising substance in the pharmaceutical industry, is gaining popularity for its potential therapeutic role in various diseases, including cancer.
On World Cancer Day (4th Feb), let’s explore what we know so far about CBD, its potential in treating cancer, and managing its side effects.
Discover the latest findings and how DSM assists pharmaceutical customers in exploring the early-stage development of CBD-based drugs to provide value-added solutions that enhance patient health worldwide.
CBD: Let’s Discuss Its Potential
Cannabis contains numerous compounds, including cannabinoids. CBD’s therapeutic potential was recognized even before the discovery of the human endocannabinoid system (ECS) in the late 1980s. The ECS, a cell-signaling network present throughout the body, is believed to regulate essential physiological functions such as sleep, mood, and cognition.
CBD and Cancer: What Do We Know?
Cancer is a complex disease influenced by both genetic and environmental factors. Despite advancements in medical care, many cancer patients still experience undesirable symptoms. While cancer treatments are continually improving, the use of cannabinoids like CBD has attracted scientific interest in managing cancer symptoms and side effects. Researchers are also exploring CBD’s potential in slowing down or inhibiting cancer growth. What have we learned so far?
Promising Anti-Cancer Properties
Extensive studies on CBD’s potential in breast cancer have demonstrated consistent and effective pro-apoptotic and anti-proliferative activity in various breast cancer cells and mouse models. CBD’s efficacy in treating breast cancer has been extensively studied, showing positive results in inhibiting cancer cell proliferation and inducing cell death.
It is also hypothesized that CBD possesses anti-cancer properties within the tumor microenvironment. By inhibiting the development of blood cells that nourish cancer, CBD may prevent its spread and reduce inflammation.
Managing Cancer Therapy Symptoms
Cancer treatments such as chemotherapy and radiation often lead to side effects like nausea, vomiting, pain, and loss of appetite. While there are medications available to address these symptoms, managing them effectively remains a challenge for many patients.
Certain cannabinoid drugs based on THC have been prescribed to alleviate chemotherapy-induced nausea and vomiting. FDA-approved Nabilone (Cesamet) is used when other anti-sickness medications fail to provide relief. Nabiximols (Sativex), a THC-CBD spray, is being studied for its potential in treating cancer pain.
Unlocking CBD’s Potential with DSM
CBD’s popularity continues to grow, and its potential benefits for cancer patients are being closely examined. Cannabinoids, including CBD, have shown anti-cancer properties in animal and cultured cancer cell models. However, more large-scale clinical trials involving humans are urgently needed to determine the efficacy and specific role of CBD in various types of cancer.
DSM has created a platform that empowers customers to understand the full potential of CBD and develop purposeful, tailored drug products. This platform facilitates early-stage drug development and fosters new scientific discoveries in the rapidly evolving CBD market. Discover the potential of CBD as a cancer treatment and learn more about the CBD offerings that can benefit global patient healthcare.
This article was written by a cannabinoid specialist at DRIP Cannabinoids. DRIP Cannabinoids joined the market in June 2020. We quickly established our mission: providing customers with the purest oil on the market, and in tandem providing a premium final product. Through each and every one of our products, DRIP strives to relieve people from the discomfort, stress, and anxiety of daily life by giving them access to cutting-edge cannabinoids such as Delta-10 and Delta-8 THC. DRIP’s formulas and procedures are all designed with the purity and safety of the customer in mind.